V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003166 | 210010429 | 1.69 | 72.8 | Adjuvant (A) | 2021-02-19 | 2021-03-06 | Vinorelbine IV | null | N | VINORELBINE | 100079108 |
| 210003167 | 210010430 | null | 76.9 | null | null | 2019-07-23 | Doce + Pertuzumab + Trastuz IV Load | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100092492 |
| 210003168 | 210010431 | 1.6 | 62.4 | Curative (C) | 2020-01-26 | 2020-03-09 | Capecitabine | null | N | CAPECITABINE | 101593551 |
| 210003170 | 210010432 | 1.67 | 68.7 | null | 2020-11-12 | 2020-11-12 | Capecitabine | null | null | CAPECITABINE | 101062258 |
| 210003173 | 210010433 | null | 67.4 | null | null | 2020-04-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101675931 |
| 210003177 | 210010434 | 1.65 | 72.1 | Adjuvant (A) | null | 2019-03-30 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100715959 |
| 210003179 | 210010435 | null | 65.7 | null | 2018-10-14 | 2018-10-16 | null | 02 | null | FEC | 100324559 |
| 210003180 | 210010436 | null | null | null | 2020-05-25 | 2020-08-07 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100849065 |
| 210003181 | 210010437 | 1.62 | 106.45 | Palliative (P) | 2020-10-28 | 2020-12-01 | VINORELBINE | N | N | VINORELBINE | 100302192 |
| 210003182 | 210010438 | 1.61 | 98.1 | null | 2018-07-17 | 2018-12-10 | Carboplatin + Docetaxel | 02 | null | LETROZOLE + PALBOCICLIB | 100777017 |
| 210003184 | 210010439 | 1.78 | 77.4 | Palliative (P) | 2019-11-05 | 2019-12-10 | CARBOPLATIN | null | N | CARBOPLATIN | 100356887 |
| 210003189 | 210010441 | 1.63 | 66.6 | Palliative (P) | 2018-10-09 | 2018-10-21 | CARBOPLATIN + GEMCITABINE | 02 | N | FULVESTRANT + PALBOCICLIB | 100328559 |
| 210003190 | 210010442 | 1.63 | 88 | Palliative (P) | null | 2019-01-10 | GemCarbo Days 1+8 | null | N | CARBOPLATIN + GEMCITABINE | 100503820 |
| 210003193 | 210010443 | 1.59 | 55 | Neo-adjuvant (N) | null | 2018-09-12 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101684009 |
| 210003194 | 210010444 | 1.73 | 100 | Palliative (P) | null | 2019-05-08 | TRASTUZUMAB DERUXTECAN | null | N | FULVESTRANT + RIBOCICLIB | 101493971 |
| 210003195 | 210010445 | null | 54.2 | null | 2017-01-21 | 2018-08-19 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101518937 |
| 210003196 | 210010446 | null | null | null | 2016-10-14 | 2016-12-24 | Pertuzumab (Maintenance) | null | null | PERTUZUMAB | 100632279 |
| 210003199 | 210010447 | null | null | null | 2017-05-11 | 2017-07-20 | Palbociclib | 02 | null | CARBOPLATIN + DOCETAXEL | 100272287 |
| 210003201 | 210010448 | 1.69 | 60 | Adjuvant (A) | 2018-01-13 | 2018-04-01 | Capecitabine | 02 | N | CAPECITABINE | 100423444 |
| 210003203 | 210010449 | 1.68 | 81.4 | Palliative (P) | null | 2021-04-23 | VINORELBINE | null | N | VINORELBINE | 101584040 |
| 210003207 | 210010451 | 1.72 | 0 | Adjuvant (A) | 2017-02-19 | 2018-05-10 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 101081006 |
| 210003209 | 210010452 | null | null | null | 2019-12-19 | 2019-12-24 | Eribulin | 02 | null | ERIBULIN | 101497595 |
| 210003211 | 210010453 | 1.64 | 82 | Palliative (P) | null | 2019-05-06 | Capecitabine | 02 | N | CAPECITABINE | 101542306 |
| 210003213 | 210010454 | 1.68 | 78 | Palliative (P) | 2021-07-04 | 2021-11-11 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 101567210 |
| 210003217 | 210010456 | null | null | null | 2019-10-21 | 2021-03-05 | VINORELBINE | 02 | null | VINORELBINE | 100329896 |
| 210003218 | 210010457 | 1.66 | 66 | Palliative (P) | 2017-10-10 | 2018-01-17 | Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101162900 |
| 210003220 | 210010458 | 1.66 | 60.6 | null | 2017-12-29 | 2017-12-31 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100029122 |
| 210003223 | 210010461 | 0 | 67.85 | Neo-adjuvant (N) | 2017-04-27 | 2017-05-15 | null | 02 | N | LETROZOLE + PALBOCICLIB | 101712169 |
| 210003224 | 210010462 | null | null | null | 2017-07-20 | 2017-07-29 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 101552581 |
| 210003225 | 210010463 | 1.47 | 69.3 | Adjuvant (A) | 2017-11-18 | 2018-02-22 | CARBOPLATIN + ETOPOSIDE | null | N | ABEMACICLIB | 101114576 |
| 210003228 | 210010465 | 1.47 | 50 | Neo-adjuvant (N) | 2018-04-04 | 2018-04-05 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101095975 |
| 210003232 | 210010466 | 1.55 | 64.3 | null | 2018-07-01 | 2018-12-05 | CARBOPLATIN + PACLITAXEL | 02 | null | TRASTUZUMAB EMTANSINE | 100731432 |
| 210003242 | 210010468 | 1.63 | null | Adjuvant (A) | 2018-06-04 | 2018-09-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101596185 |
| 210003245 | 210010470 | 1.7 | 71 | null | 2017-02-18 | 2017-05-12 | null | 02 | null | FEC + DOCETAXEL | 101272057 |
| 210003246 | 210010471 | 1.52 | 82 | Palliative (P) | 2019-06-30 | 2021-06-16 | Capecitabine | 02 | N | CAPECITABINE | 101585242 |
| 210003257 | 210010474 | 1.63 | 86 | Neo-adjuvant (N) | null | 2019-07-09 | Fulvestrant + Palbociclib | 02 | N | EPIRUBICIN | 101116878 |
| 210003260 | 210010475 | 1.67 | 71.35 | null | 2015-11-24 | 2017-02-23 | Neratinib | 02 | null | NERATINIB | 101642636 |
| 210003261 | 210010476 | 1.54 | 80 | Adjuvant (A) | null | 2018-10-27 | CONCEPT Trial | 02 | N | EVEROLIMUS + EXEMESTANE | 100518616 |
| 210003263 | 210010477 | 1.61 | null | Adjuvant (A) | 2018-09-25 | 2018-10-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101824256 |
| 210003264 | 210010478 | 1.74 | 69.8 | null | 2020-01-23 | 2020-01-23 | Eribulin | null | null | ERIBULIN | 100468383 |
| 210003269 | 210010479 | 1.7 | 63.4 | null | 2021-03-19 | 2021-03-27 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100582502 |
| 210003270 | 210010480 | 1.66 | 76 | null | 2016-08-12 | 2016-12-15 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100006670 |
| 210003271 | 210010481 | 1.57 | 90.2 | Palliative (P) | null | 2019-03-12 | ROSCO Trial | 02 | N | FLUOROURACIL + OXALIPLATIN | 100350490 |
| 210003273 | 210010482 | 1.69 | 71.6 | null | 2019-05-28 | 2019-07-02 | GemCarbo Days 1+8 | 02 | null | FEC | 101807706 |
| 210003274 | 210010483 | 1.55 | 77 | Adjuvant (A) | 2019-07-10 | 2019-07-24 | Neratinib | null | N | NERATINIB | 101669803 |
| 210003275 | 210010484 | 1.66 | 55.3 | null | null | 2019-06-20 | Eribulin | 02 | null | ERIBULIN | 101657148 |
| 210003280 | 210010487 | 1.69 | 84.5 | Adjuvant (A) | 2019-06-07 | 2019-07-03 | Eribulin | 02 | N | ERIBULIN | 101310569 |
| 210003281 | 210010488 | 1.68 | 95 | null | null | 2019-04-20 | Capecitabine | 02 | null | CAPECITABINE | 100244001 |
| 210003282 | 210010489 | 1.71 | 76.3 | Adjuvant (A) | 2018-04-21 | 2018-04-30 | null | 02 | N | NAB-PACLITAXEL | 100093197 |
| 210003283 | 210010490 | 1.58 | 96.3 | null | 2019-02-03 | 2019-03-29 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101017890 |